Master the Skills Needed to Overcome the Challenges of Modern Paragraph IV Litigation

Each fall, leading pharmaceutical patent litigators for brand name and generic drug companies gather at the Paragraph IV Disputes Master Symposium in Chicago to receive up-to-the-minute information on the latest developments affecting Hatch-Waxman litigation and participate in significant peer-to-peer networking opportunities.

As the industry prepares to address the fallout of global pharmaceutical patent losses of billions of dollars and the impact of evolving law, regulation and policy impacting the Hatch-Waxman landscape, the time for this conference has never been more relevant.


Interested? Don’t wait until the fall!

Join us at our flagship event Paragraph IV Disputes in New York City this April. Learn More


A Few Words From Our 2019 Co-Chairs:

Ryan M. Daniel

Ryan M. Daniel

Chief Patent Counsel
Fresenius Kabi USA, LLC

“I’m excited to participate in ACI’s 2019 Paragraph IV Conference here in Chicago. It’s a welcome opportunity to engage with colleagues regarding the evolving landscape of Hatch-Waxman law and the pharmaceutical industry.”

Andrea Hutchison

Andrea Hutchison

Associate General Counsel, IP Litigation
Gilead Sciences

“ACI’s Paragraph IV Conference series offers a great opportunity to convene and exchange ideas with subject matter experts from all over the country. I am delighted to return to Chicago and to meet with our many talented Hatch-Waxman litigators and colleagues in the industry.”


Sign up and stay tuned for more exciting program announcements and our incredible speaker line-up

WHO YOU WILL MEET

Patent attorneys and litigators (in-house & law firms) who represent:

  • Brand name pharmaceutical companies
  • Generic pharmaceutical companies
  • Biopharmaceutical companies

WHAT OUR ATTENDEES HAVE TO SAY

“This is the best high-level conference on Paragraph IV disputes…”

Senior VP, Intellectual Property

Endo Pharmaceuticals

“…the smaller breakout sessions allow participants to tailor their conference experience to meet their specific needs, and exchange ideas in an intimate and dynamic environment”

Senior VP and Head, Intellectual Property

Eagle Pharmaceuticals


Attend the conference that the “Who’s Who” of Hatch-Waxman litigators have designated as the forum which sets the standards for Paragraph IV practice. Register now and be part of the prestigious meeting of the minds.

Registration is Now Open. Enjoy Early Bird Rates to Save $400!

Event Contacts

Sponsorship Opportunities:

American Conference Institute
Email Us

Media Partnership Opportunities:

Linda Lam
Email Us

Programme Information and Speaking:

Joseph Gallagher
Email Us

Connect With Us

Twitter

@ACI_Pharma
#ACIPIV